Patient Characteristics and General Practitioners' Advice to Stop Statins in Oldest-Old Patients: a Survey Study Across 30 Countries

Author(s):
Ploeg, M.A. van der; Streit, S.; Achterberg, W.P. (0000-0001-9227-7135); Beers, E.; Bohnen, A.M.; Burman, R.A.; Collins, C.; Franco, F.G.; Gerasimovska-Kitanovska, B.; Gintere, S.; Bravo, R.G.; Hoffmann, K.; Iftode, C.; Pestic, S.K.; Koskela, T.H.; Kurpas, D.; Maisonneuve, H.; Mallen, C.D.; Merlo, C.; Mueller, Y.; Muth, C.; Petrazzuoli, F.; Rodondi, N.; Rosemann, T.; Sattler, M.; Schermer, T.; Ster, M.P.; Svadlenkova, Z.; Tatsioni, A.; Thulesius, H.; Tkachenko, V.; Torzsa, P.; Tsopra, R.; Tuz, C.; Vaes, B.; Viegas, R.P.A.; Vinker, S.; Wallis, K.A.; Zeller, A.; Gussekloo, J. (0000-0001-7186-8278); Poortvliet, R.K.E. (0000-0001-6521-8770)
Published
2019
Publication type
Article / Letter to editor
hydroxymethylglutaryl-CoA reductase inhibitorscardiovascular diseasesdrug therapypalliative caregeneral practitionersclinical decision-making
Date issued
2019-09-30
Language
English
Is part of
Journal of General Internal Medicine (2019), Vol. 34, no. 9, p. 1751-1757
hdl
1887/120573
doi
10.1007/s11606-018-4795-x